Fate Therapeutics (FATE) – Analyst Ratings
-
Wells Fargo Assumes Fate Therapeutics (FATE) at Equal Weight
-
H.C. Wainwright Downgrades Fate Therapeutics (FATE) to Neutral
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to FATE Stock Lookup